Fax: (214) 648-7876.
Renal tumor ablation is a function of patient selection and technique—Not the ablation technology†
Article first published online: 24 SEP 2008
Copyright © 2008 American Cancer Society
Volume 113, Issue 10, pages 2623–2626, 15 November 2008
How to Cite
Cadeddu, J. A. and Raman, J. D. (2008), Renal tumor ablation is a function of patient selection and technique—Not the ablation technology. Cancer, 113: 2623–2626. doi: 10.1002/cncr.23897
See referenced original article on pages 2671–80, this issue.
- Issue published online: 3 NOV 2008
- Article first published online: 24 SEP 2008
- Manuscript Accepted: 1 JUL 2008
- Manuscript Received: 26 JUN 2008
In this issue, although the authors of a meta-analysis of the existing published literature on cryoablation and radiofrequency ablation (RFA) acknowledge multiple shortcomings in their data, they nevertheless present a conclusion that suggests the superiority of cryoablation over RFA. However, differences in ablation techniques and patient selection may influence the rates of tumor retreatment and disease recurrence, making it difficult to reach any conclusion regarding the superiority of 1 ablation technique over another.